Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

The latest data is out on the correlation between treatments for so-called “Low T” and cardiac events such as heart, attack, stroke and pulmonary embolism, and the results are truly frightening.
The most recent study was funded by the National Institutes of Health and published in the journal of PLOS ONE. The study evaluated over 55,000 men and indicated that prescription Testosterone Therapy (also commonly known as Low T Treatment) significantly increased the risk of heart attacks in men over the age of 65 and, in younger men with a history of heart disease. This new study is the largest and most comprehensive so far in a number of such studies in recent years, which have indicated the risks of testosterone therapy.
The study concluded that the risk of heart attacks in the first three months of testosterone therapy is doubled in men over age 65 with no prior heart conditions and the risk of heart attack in men below 65 with a history of heart disease is almost tripled.
The PLOS One article comes on the heels of study results recently published in the Journal of the American Medical Association in November 2013. That study evaluated over 8,700 men with low testosterone in the Veterans Administration health care system who underwent certain heart procedures and found that testosterone therapy was associated with an increased risk of adverse outcomes including stroke, heart attack and death.
Currently, the labels of these products that are being used by tens of millions of American men contain no warning an increased risk of cardiac or cardiovascular events. On January 30, 2014, after the release of these two studies, the FDA issued a “Drug Safety Communication” announcing it is reassessing the safety of these products and continuing to evaluate available data regarding an increased risk of cardiovascular events.
Testosterone Therapy can come in several forms, such as: gels, patches, under arm topical solutions, pellets, and injections, and include the following brands:

  • Androgel®
  • Axiron®
  • Fortesta®
  • Testim®
  • Testopel®
  • Androderm®
  • Depo-Testosterone®
  • Striant®
  • Bio-T-Gel®
  • Delatestryl®

NOTE: If you are taking prescription testosterone supplement therapy such as those listed above, you should discuss the health risks with your doctor. Do not stop taking any medication until you have discussed the health risks and benefits of doing so with your physician or health care provider.
If you or a loved one was prescribed a testosterone supplement and suffered a cardiac or clotting event, please contact The Michael Brady Lynch Firm for a no cost, no obligation evaluation of your case.
About the Firm: The Michael Brady Lynch Firm is a trial firm with a focus on pharmaceutical mass tort cases involving SSRI and Anti-Seizure Medication Birth Defects including Lexapro, Zoloft, Effexor, Prozac, Celexa, Paxil, Depakote and Topamax, Testosterone cardiac events, Mirena IUD, Pradaxa internal bleeding, Actos Bladder Cancer, Lipitor diabetes cases, and medical device cases including DePuy Hip and Trans-Vaginal Mesh cases. Contact us today if you or someone you know has experienced side effects involving these products.

What Our Clients Are Saying